These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1068542

  • 21. Decreasing risk of leukaemia during prolonged follow-up after mitobronitol therapy for polycythaemia vera.
    Kelemen E, Tura S, Burger T.
    Lancet; 1987 Sep 12; 2(8559):625. PubMed ID: 2887907
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H.
    Haematologica; 1972 Apr 12; 57(11):775-86. PubMed ID: 4200312
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A reassessment of demecolcine ('Colcemid') in the treatment of chronic granulocytic leukaemia.
    Spiers AS, Kaur J.
    Clin Oncol; 1975 Dec 12; 1(4):285-90. PubMed ID: 1061646
    [No Abstract] [Full Text] [Related]

  • 28. Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane.
    Institóris L, Eckhardt S, Horváth IP, Sellei C.
    Arzneimittelforschung; 1966 Jan 12; 16(1):45-50. PubMed ID: 5233532
    [No Abstract] [Full Text] [Related]

  • 29. Chemotherapy of chronic myelocytic leukemia.
    Galton DA.
    Semin Hematol; 1969 Oct 12; 6(4):323-43. PubMed ID: 4900650
    [No Abstract] [Full Text] [Related]

  • 30. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
    Urban C, Slavc I, Kaulfersch W, Teubl I.
    Wien Klin Wochenschr; 1987 Mar 06; 99(5):144-9. PubMed ID: 3554777
    [Abstract] [Full Text] [Related]

  • 31. New trends in the management of chronic myeloid leukaemia.
    Tura S.
    Haematologica; 1972 Apr 06; 57(11):741-52. PubMed ID: 4200309
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dibromomannitol and chronic myeloid leukaemia results of a cooperative study.
    Haematologica; 1972 Apr 06; 57(11):732-40. PubMed ID: 4200308
    [No Abstract] [Full Text] [Related]

  • 36. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L, Falda M, Rossi M, Infelise VE.
    Panminerva Med; 1973 Sep 06; 15(9):275-7. PubMed ID: 4533778
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of chronic myeloid leukemia with dibromomannitol].
    Clément F, Saillen R.
    Schweiz Med Wochenschr; 1970 Nov 14; 100(46):1995-7. PubMed ID: 5279364
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of chronic myeloid leukemia with Dibromomannitol].
    Saillen R, Clément F.
    Schweiz Rundsch Med Prax; 1970 Sep 22; 59(38):1325-33. PubMed ID: 5283076
    [No Abstract] [Full Text] [Related]

  • 40. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
    Galton DA.
    Haematol Lat; 1969 Sep 22; 12(3):703-9. PubMed ID: 5273182
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.